IONS- Ionis Pharmaceuticals, Inc.

Name: Ionis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ionis Pharmaceuticals, Inc. (IONS) has 21 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. IONS is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Monia Brett P	260.3K	$20.03M	-
Dir	Berthelsen Spencer R	164.0K	$12.63M	-8,000
VP	Bennett C Frank	100.3K	$7.72M	-
VP	Kordasiewicz Holly B.	83.3K	$6.41M	-60,846
CFO	Hougen Elizabeth L	82.7K	$6.36M	-

Activity

Buys and sells only

Transactions

10 filings · page 20

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 7, 2020	Crooke Stanley T	Exec Chairman Of The Board	Sell	11,000	$51.67	$568,350.50	-0.8%
Dec 4, 2020	Bennett C Frank64	Chief Scientific Officer	Sale+OE	7,947	$51.04	$405,614.88	-19.7%
Dec 4, 2020	Monia Brett P60	Chief Executive Officer	Sale+OE	23,840	$51.04	$1,216,793.60	-45.2%
Dec 2, 2020	Bennett C Frank64	Chief Scientific Officer	Sale+OE	7,053	$51.32	$361,959.96	-17.8%
Dec 2, 2020	Monia Brett P60	Chief Executive Officer	Sale+OE	21,160	$51.32	$1,085,931.20	-42.3%
Nov 25, 2020	Hougen Elizabeth L55	EVP, Finance &CFO	Sale+OE	21,680	$50.05	$1,085,084.00	-40.0%
Nov 25, 2020	Crooke Stanley T	Exec Chairman Of The Board	Sale+OE	12,990	$50.05	$650,149.50	-86.5%
Nov 25, 2020	Geary Richard S65	EVP, Development	Sale+OE	11,920	$50.05	$596,596.00	-28.1%
Nov 25, 2020	Parshall B Lynne74	Director	Sale+OE	3,590	$50.05	$179,679.50	-5.1%
Nov 24, 2020	Parshall B Lynne74	Director	Sale+OE	3,910	$50.25	$196,466.20	-2.8%

← PrevPage 20Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC